Navigation Links
Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
Date:6/2/2008

PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) today announced preliminary data from an ongoing Phase 1 study of MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody. Data presented from patients with recurrent or treatment-refractory cancer in the study included the safety, tolerability and pharmacokinetic profile of single-dose MDX-1106. In addition, preliminary evidence of anti-tumor activity was observed, including one patient with colorectal carcinoma who experienced a confirmed partial response that has been durable for more than 6 months. Tumor regressions (tumor shrinkage that did not meet the criteria for partial response) were also observed in four additional patients, including two patients with melanoma, one patient with non-small cell lung cancer, and one with renal cell carcinoma. These preliminary study results were presented in an oral presentation by investigator Julie Brahmer, M.D., Assistant Professor of Oncology from the Sidney Kimmel Cancer Comprehensive Center at Johns Hopkins University at the annual meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago. (Abstract #3006)

"We are pleased with the safety profile and preliminary evidence of anti- tumor activity from this first human clinical trial of MDX-1106," said Geoffrey M. Nichol, MBChB, Senior Vice President of Product Development at Medarex. "We look forward to the further development of this novel immunotherapy, and plans are underway to initiate a Phase 2 trial of MDX-1106 in cancer this year."

In the single-dose Phase 1 trial, 24 patients initially enrolled in the dose-escalation portion of the trial, and an additional 15 patients are n
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
2. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
3. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
4. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
5. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
6. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
7. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
8. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
9. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
10. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- IBM Watson Health (NYSE: IBM ) today announced that ... Clinic to advance patient health by applying the cognitive ... As Watson,s capabilities are applied to EHRs, patients ... the medical factors that could impact an individual,s health and ... – some of the largest and most-recognized healthcare ...
(Date:5/5/2015)... MISSION, Kan. , May 5, 2015 ... priorities for you? If you,re like most adults, monitoring ... of your health care routine. But what about vision ... When adults reach their 40s, they ... which can impact their daily lives and job performance. ...
(Date:5/5/2015)... 2015  Desert Valley Medical Center, named a Top 100 ... first U.S. hospital to deploy the wireless Leaf Patient Monitoring ... the duration of labor and risk of caesarian births. ... of caesarean birth is reduced in mothers who are upright ... labor are given epidurals and tend to lie in their ...
Breaking Medicine Technology:IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4
... explosive devices at East Midlands and Dubai airports has once ... by terrorism. One of the bombs posted from Yemen last ... in Dubai, Qatar Airways has said. The device was carried ... the powerful explosive PETN, which is difficult to detect. ...
... 2010 ( http://www.myprgenie.com ) -- Medrium, Inc., ( ... healthcare information technology companies, has received an EHR module ... of enabling providers to meet the Stage 1 meaningful ... American Recovery and Reinvestment Act (ARRA). Medrium,s product is ...
Cached Medicine Technology:Marken Rapidly Responds to Global Supply Chain Security Measures 2Medrium Awarded Electronic Health Record (EHR) Module Certification by Drummond Group 2Medrium Awarded Electronic Health Record (EHR) Module Certification by Drummond Group 3Medrium Awarded Electronic Health Record (EHR) Module Certification by Drummond Group 4
(Date:5/5/2015)... global lab automation market is expected to reach $5,105.7 ... an estimated CAGR of 6.7% from 2015 to 2020. ... basis of equipment and software, application, type of automation, ... Lab Automation Market is classified into clinical diagnostics, drug ... a major application of the lab automation market. Developing ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 The newly minted ... the experiences of Dr. Brad Reedy from his 20 ... Regan was asked why she chose to publish a parenting book ... a parent (and publisher) is the idea that it is a ... and our children are on the trek sometimes together and sometimes ...
(Date:5/5/2015)... Atlanta, Georgia (PRWEB) May 05, 2015 ... Software of Victoria BC announced the Skedans Sensor ... The platform, for mobile and web app developers, provides ... from airborne and mobile sensors. , The Skedans Sensor ... at the intersection of the Internet of Things, Web ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... mission-focused company serving the federal government, today announced ... (CCSi). CCSi provides solutions exclusively to federal ... extensive experience in cyber security, health services, and ... processes and industry-relevant credentials as a Third Party ...
(Date:5/5/2015)... SC (PRWEB) May 05, 2015 On May, ... episode with Charleston musician Irene Rose about alternatives for youngsters ... Rose, “How did you get the idea for starting a ... replies, “I run an entertainment company called Once Upon a ... them moral lessons through songs and even scripture. We play ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2
... doesn,t have excess stomach acid, study finds, , , MONDAY, ... anti-reflux medications to infants, new research suggests. , The ... given anti-reflux medications, which work by lowering levels of ... four out of five infants included in the study ...
... Introduces Simplified Issue Underwriting for Return of Premium ... make the purchase of life,insurance easier and more ... simplified issue underwriting process for its Return of,Premium ... amounts from,$100,000 to $249,999. "ROP Term with Simplified ...
... Two nonprofit,foundations devoted to the support, treatment and ... as "Fragile X" have,agreed to a formal merger as ... (NFXF) and Florida-based Conquer Fragile X,Foundation (CFXF) will now ... X community. The agreement calls for the NFXF ...
... Associates has been,awarded a $15 million, 7-year contract ... the U.S. Department of Health and Human Services,Administration ... major evaluation,of employment and self-sufficiency programs. The programs ... for Needy Families,(TANF) benefits, as well as families ...
... Inpatient Certification ... ... Siemens Medical,Solutions (http://www.usa.siemens.com/healthcareit ) today announced that,Soarian(R) Clinicals V2.0C5 ... conditionally CCHIT Certified(sm),status from the Certification Commission for Healthcare Information,Technology ...
... 5, 2007 Human Genome Sciences, Inc. (Nasdaq: ... a Phase 2b clinical trial of the investigational ... in treatment-naive patients with genotype 1 chronic hepatitis ... Albuferon treatment groups reported fewer missed days of ...
Cached Medicine News:Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 2Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 3Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 2Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 3Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 4Health News:Fragile X Foundations Sign Merger Agreement 2Health News:Fragile X Foundations Sign Merger Agreement 3Health News:Abt Associates to Lead Major Evaluation of Programs Aimed at Promoting Self-Sufficiency for Disadvantaged Families 2Health News:Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check 2Health News:Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check 3Health News:Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check 4Health News:HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 2Health News:HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 3
Inquire...
Inquire...
Agarose I (Molecular Biology Grade) - A regular melting temperature agarose for electrophoresis requiring an exceptional level of purity with unequaled performance....
... a premium agarose used for isolating DNA ... produces clear sharp bands, with no smearing ... UltraClean Forensic Agarose is tested and certified ... activity and DNA contamination. Meets ...
Medicine Products: